Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients

NCT00271284 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: insulin glulisine / insulin glargine
DRUG: insulin glulisin / insulin detemir

Sponsor

Sanofi